Avanti Europe AG

Startseite
Schweiz
Ormalingen
Avanti Europe AG

Wegbeschreibung Website Service kontaktieren

We are reaching far beyond conventional consultancy as we are supporting companies with “hands-on?

13/10/2026

A key requirement in the new FDA HF Guidance (May 2026): for modified devices, assess the final finished device holistically — not just the change. Cumulative modifications can shift the risk profile even when individual changes seem minor.

Missing this can get your Category 2 rationale rejected.

Need help? Talk to us: https://www.avanti-europe.ch/home/inquire/

09/10/2026

CAPA is one of the most frequently cited areas in FDA and notified body audits. Under the QMSR, the framework aligns closely with ISO 13485 clause 8.5 — with greater emphasis on risk-based prioritisation.

Common failures: symptoms treated instead of root cause, no effectiveness check, backlogs without documented risk priority.

Is your CAPA process audit-ready? We can help: https://www.avanti-europe.ch/home/inquire/

06/10/2026

👨‍💼 Need a PRRC but no clearance for a full-time hire?

The Person Responsible for Regulatory Compliance (PRRC) is a mandatory role under MDR 2017/745. Every manufacturer or Authorized Representative placing medical devices on the EU or Swiss market needs one.

But not every company needs, or can afford, a full-time internal PRRC.

That’s where Avanti Europe’s Rent-a-PRRC service comes in:

✅ Your personal, dedicated PRRC
✅ Fully qualified and experienced
✅ Available immediately
✅ Scale up or down as your business needs change

Scale your certified business at the touch of a button and without the overhead of a permanent hire.

We also act as EC REP (Germany) and CH REP (Switzerland), covering both markets under one roof.

Interested? Find out more: https://bit.ly/3QhjAef

02/10/2026

Medical device cybersecurity is a hard regulatory requirement. FDA data shows 35% of incidents involve insecure communication, 29% insecure firmware. ENISA’s top risks include data loss and human life at risk.

For SaMD: cybersecurity must be integrated into risk management from day one, not added at submission.

Is your SaMD cybersecurity audit-ready? Talk to us: https://www.avanti-europe.ch/home/inquire/

29/09/2026

The PRRC isn’t just a pre-market role. Post-market obligations are substantial: PMS, PSUR, PMCF, SSCP — all must be actively overseen.

Is your PMS system connected to your PRRC function?

Talk to us: https://www.avanti-europe.ch/home/inquire/

25/09/2026

Supplier management is one of the most common FDA 483 observations — and the QMSR tightens requirements. Supplier qualification must be ongoing, not a one-time activity.

Is your supplier management program QMSR-ready?

We can help: https://www.avanti-europe.ch/home/inquire/

22/09/2026

MDR compliance costs escalated up to 100% vs. prior EU directives — and that’s good news for companies who invested early.

Companies that withdrew EU products or deferred compliance left market gaps. Companies with mature QMS infrastructure absorbed the costs and maintained position.

Your compliance investment is also competitive protection.

18/09/2026

The Use-Related Risk Analysis (URRA) is the foundation of every FDA HF submission. Critical tasks — ones where errors could cause serious harm — drive your HF Submission Category and documentation requirements.

Weak URRAs are one of the top FDA deficiency reasons. Need URRA support?

Talk to us: https://www.avanti-europe.ch/home/inquire/

15/09/2026

Process validation CCI for fully assembled autoinjectors requires different methods than primary container testing — no optical access, outgassing plastics, dead volumes.

The approach: tracer gas testing, dye ingress bracketing, HVLD where geometry allows. Bridging Phase 1 to Phase 2 acceptance criteria is the key regulatory requirement.

Ready to design your CCI validation protocol? Let’s talk: https://www.avanti-europe.ch/home/inquire/

11/09/2026

Risk management for SaMD is fundamentally different from physical devices. Bugs, data integrity failures, cybersecurity, interoperability — FMEA alone doesn’t capture all of it.

Combining bottom-up FMEA with top-down Fault Tree Analysis is the standard approach. Is your SaMD risk file comprehensive?

We can help: https://www.avanti-europe.ch/home/inquire/

Adresse

Zwischbachweg 14
Ormalingen
4466

Website

https://www.avanti-europe.ch/

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn Avanti Europe AG etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.